Search
for
Sort by
Research 301–330 of 1000+
- Recent advances in thiasteroids chemistry
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Recent advances in neuropeptide-related omics and gene editing: Spotlight on NPY and somatostatin and their roles in growth and food intake of fish
- Molecular Mechanisms and Therapeutic Advances in Androgenetic Alopecia
- Recent Advances in Hair Biology and in Treatments of Androgenetic Alopecia.
- Targeting integrin pathways: mechanisms and advances in therapy
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Outcome and clinical–biological characteristics of patients with advanced breast cancer undergoing removal of ovarian/pelvic metastases
- Advances in male hormone substitution therapy
- Advances in molecular pathogenesis of hidradenitis suppurativa: Dysregulated keratins and ECM signaling
- Editorial Note on Next-Generation Therapies and Advance Acne Treatment
- The premature catagen induced by estrogen was accompanied with advance apoptosis of precortex cells.
- A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- Brimonidine Beyond a Single Specialty: Pharmacological Profile, Dermatologic Applications, and Advances in Drug Delivery Systems
- Diversification and Specialization of Touch Receptors in Skin
- Severe Insulin Resistance in a Pediatric Patient: Key Areas to Address in the Screening
- TTNPB Promotes Human Pluripotent Stem Cell‐to‐Neural Stem Cell Transition via Modulation of Chromatin Accessibility and the S‐(5′‐adenosyl)‐L‐homocysteine/Choline Metabolic Network
- Extra-nasal odorant receptors: molecular mechanisms and therapeutic implications
- A Top-Down Design Approach for Generating a Peptide PROTAC Drug Targeting Androgen Receptor for Androgenetic Alopecia Therapy
- Androgenic Alopecia: Recent Understanding of the Androgenetic Receptor-Mediated Molecular Mechanisms and Current Pharmacotherapy
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- Understanding key symptoms, side effects, and impacts of HR+/HER2- advanced breast cancer: qualitative study findings
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Genetic and molecular aspects of androgenetic alopecia
- Beyond acne: Current aspects of sebaceous gland biology and function
- Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer
- Non-canonical dimerization of the androgen receptor and other nuclear receptors: implications for human disease
- New developments in our understanding of acne pathogenesis and treatment
- Through the lens of hair follicle neogenesis, a new focus on mechanisms of skin regeneration after wounding